Feedback / Questions
Undisclosed Activin E antibody - iBio, AstralBio
https://www.globenewswire.com/news-release/2025/04/22/3065407/0/en/iBio-Expands-Cardiometabolic-and-Obesity-Pipeline-through-Licensing-of-First-in-Class-Antibody-Targeting-Activin-E-from-AstralBio.html
Apr 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next